Devyser Diagnostics AB (publ) (STO:DVYSR)
108.20
+0.20 (0.19%)
At close: Dec 5, 2025
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 56.40M SEK in the quarter ending September 30, 2025, with 15.81% growth. This brings the company's revenue in the last twelve months to 242.70M, up 22.51% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
242.70M
Revenue Growth
+22.51%
P/S Ratio
7.42
Revenue / Employee
2.25M
Employees
121
Market Cap
1.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 216.90M | 47.60M | 28.12% |
| Dec 31, 2023 | 169.30M | 42.70M | 33.73% |
| Dec 31, 2022 | 126.60M | 33.12M | 35.43% |
| Dec 31, 2021 | 93.48M | 27.79M | 42.31% |
| Dec 31, 2020 | 65.69M | 1.39M | 2.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |